Tolka AI Therapeutics
PrivateLast Round
Seed
Jun 13, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Tolka AI Therapeutics is a biotechnology company that has developed an AI-based platform for drug discovery for complex inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Drug Discovery
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tolka AI Therapeutics Comparables
Compare Tolka AI Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Medea Biopharma | 73% | |
| Locus Biosciences | 73% | |
| BioNTech | 69% |
Tolka AI Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 13, 2024 |
Tolka AI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Khosla Ventures | Angel |
| NIH RADx | Angel |
| Draper Associates | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 438% MoM, reaching 10.7K.
- Feb 3, 2026
Monthly visitors increased 269% MoM.
Tolka AI Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Tolka AI Therapeutics's valuation, stock price, and market status.
Is Tolka AI Therapeutics a public or private company?
Tolka AI Therapeutics is a private company.
What is the current stock price of Tolka AI Therapeutics?
Tolka AI Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Tolka AI Therapeutics worth (valuation)?
Valuation information for Tolka AI Therapeutics is not publicly available.
Can I buy Tolka AI Therapeutics stock?
Tolka AI Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Tolka AI Therapeutics's last funding round?
Tolka AI Therapeutics's most recent funding round was Seed on June 13, 2024.
Who are the main investors in Tolka AI Therapeutics?
Key investors in Tolka AI Therapeutics include Khosla Ventures, NIH RADx, Draper Associates.
Will Tolka AI Therapeutics IPO soon?
No public IPO plans have been announced for Tolka AI Therapeutics.
How can I track Tolka AI Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tolka AI Therapeutics's secondary market activity and sign up for updates.